Core Insights - The technology developed for intelligent detection and evaluation of beauty and health products has successfully overcome key technical bottlenecks, providing significant support for the high-quality development of China's beauty and health industry [1][2] Group 1: Technological Achievements - The research team established an AI risk detection system and developed eight exclusive detection methods for high-concern substances, achieving an analysis accuracy rate exceeding 95% [2] - A "four-dimensional three-level" quality grading model framework was constructed, along with a database covering over 200 banned and restricted substances [2] - The team successfully developed a skin moisture detection prototype and a visual-touch fusion dexterous hand system, with a positioning error of less than or equal to 3% [2] Group 2: Application and Impact - The technology provides high-sensitivity detection tools and quality grading models for regulatory agencies, aiding in precise regulation [2] - A scientific quality grading system is established to help consumers identify product authenticity and protect their legal rights [2] - The remote evaluation system can reduce R&D costs for companies and shorten the time to market, with related patents and technical standards having industrialization potential [2]

Group 1 - The event "Industrial and Information Lecture Hall" focused on the digital transformation of the biopharmaceutical industry, with over 100 participants including government officials and industry representatives [1][3] - The event included site visits to Hengxiutang Pharmaceutical Co., Ltd. and Sinocare Inc., where attendees learned about digital transformation experiences [3] - More than 100 small and medium-sized enterprises in Changsha's biopharmaceutical sector are participating in the third batch of transformation trials, creating multiple typical application scenarios and innovative dual-line integration models [3] Group 2 - Hengxiutang Pharmaceutical's digital transformation leader shared insights on the underlying logic and implementation paths of digital transformation, addressing pain points in traditional Chinese medicine manufacturing [3] - The next steps for the industrial system include building a "government-industry-university-research-application" platform to tackle common technologies like AI quality control and drug traceability [3] - The initiative aims to support benchmark enterprises in sharing transformation experiences and encourage personalized intelligent manufacturing scenarios, while also focusing on cultivating interdisciplinary talent through collaboration with universities and research institutions [3]